| 产品名称 |
点击数 |
| Human IgG4 (S228P) Recombinant Isotype Control Antibody, PE|人IgG4(S228P)重组同型对照抗体,PE标记(靶标:免疫球蛋白G4(S228P突变体)) |
515 |
| Canine IgG4, lambda Recombinant Isotype Control Antibody, PE|犬IgG4,λ型重组同型对照抗体,PE标记(靶标:免疫球蛋白G4,λ轻链型) |
200 |
| Anti-Mouse Ly6g/Ly-6G.1 Recombinant Antibody, PE|抗小鼠Ly6g/Ly-6G.1重组抗体,PE标记(靶标:淋巴细胞抗原6G/Ly-6G.1) |
497 |
| Anti-Human CD8 Recombinant Antibody, PE|抗人CD8重组抗体,PE标记(靶标:CD8分子) |
379 |
| Anti-Human CD8 Recombinant Antibody, PE|抗人CD8重组抗体,PE标记(靶标:CD8分子) |
376 |
| Anti-Human CD8 Recombinant Antibody, PE|抗人CD8重组抗体,PE标记(靶标:CD8分子) |
543 |
| Anti-Mouse CD8 Recombinant Antibody, PE|抗小鼠CD8重组抗体,PE标记(靶标:CD8分子) |
211 |
| Anti-Mouse CD16/CD32 Recombinant Antibody, PE|抗小鼠CD16/CD32重组抗体,PE标记(靶标:IgG Fc段受体III/II (CD16/CD32)) |
481 |
| Anti-Mouse TIMD4/TIM-4 Recombinant Antibody, PE|抗小鼠TIMD4/TIM-4重组抗体,PE标记(靶标:T细胞免疫球蛋白和黏蛋白结构域蛋白4/TIM-4) |
554 |
| Anti-Human TNFRSF25 Recombinant Antibody, PE|抗人TNFRSF25重组抗体,PE标记(靶标:肿瘤坏死因子受体超家族成员25) |
505 |
| Anti-Human TCR Vα Recombinant Antibody, PE|抗人TCR Vα重组抗体,PE标记(靶标:T细胞受体α链可变区) |
235 |
| Human IgG1, lambda Isotype Control Antibody, PE|人IgG1,λ型同型对照抗体,PE标记(靶标:免疫球蛋白G1,λ轻链型) |
368 |
| Anti-Human VSIG4/CRIg Recombinant Antibody , PE|抗人VSIG4/CRIg重组抗体,PE标记(靶标:V型免疫球蛋白结构域含T细胞活化抑制因子4/补体受体免疫球蛋白) |
296 |
| Anti-Human VSIG4/CRIg Recombinant Antibody , PE|抗人VSIG4/CRIg重组抗体,PE标记(靶标:V型免疫球蛋白结构域含T细胞活化抑制因子4/补体受体免疫球蛋白) |
395 |
| Anti-Human KLRG1/CLEC15A Recombinant Antibody , PE|抗人KLRG1/CLEC15A重组抗体,PE标记(靶标:杀伤细胞凝集素样受体G1/CLEC15A) |
540 |
| Anti-Human GPR20 Recombinant Antibody , PE|抗人GPR20重组抗体,PE标记(靶标:G蛋白偶联受体20) |
484 |
| Anti-Human SLC5A8 Recombinant Antibody , PE|抗人SLC5A8重组抗体,PE标记(靶标:溶质载体家族5成员8) |
271 |
| Anti-Human TMIGD2/CD28H/IGPR1 Recombinant Antibody , PE|抗人TMIGD2/CD28H/IGPR1重组抗体,PE标记(靶标:跨膜和免疫球蛋白结构域蛋白2/CD28H/IGPR1) |
319 |
| Anti-Mouse H2-L Recombinant Antibody, PE|抗小鼠H2-L重组抗体,PE标记(靶标:小鼠MHC I类L位点抗原) |
275 |
| Anti-Human HHLA2 Recombinant Antibody, PE|抗人HHLA2重组抗体,PE标记(靶标:人内源性逆转录病毒H长末端重复序列相关蛋白2) |
379 |